Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Pfizer pivots to 'externalization" of rare disease programs

<< Previous

Bullboard Posts

Next >>

Comment by fox7mfon Jan 08, 2023 4:48pm

168 Views

Post# 35209946

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Pfizer pivots to 'externalization" of rare disease programs

It's been established for quite sometime that Buck only spews moronic, self serving, bashing pablum, so why even reference him/her? He/she was only on pt once when it stated the future valuation of Onc could be $50b;) Let's talk about the 90 day exclusivity that is about to end. Let's talk about the pressure on PFE to table an offer. Maybe news this week from the JP Morgan Healthcare event which starts demain?

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?